AV
Von Bueren, André
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets | Neuro-oncology advances |  | 2025 | 11 | 10 | ||
| MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma | Acta neuropathologica | | 2025 | 21 | 19 | ||
| Dental Health of Childhood Cancer Survivors-A Report From the Swiss Childhood Cancer Survivor Study (SCCSS) | Pediatric blood & cancer | | 2025 | 13 | 3 | ||
| Long-term follow-up of a child with EWSR1-BEND2 fused spinal astroblastoma | Pediatric neurosurgery | | 2024 | 41 | 21 | ||
| European standard clinical practice recommendations for paediatric high-grade gliomas | EJC paediatric oncology | | 2024 | 20 | 22 | ||
| Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype | Acta neuropathologica communications | | 2024 | 14 | 5 | ||
| Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa - Results of the HIT 2000 trial | Neuro-oncology |  | 2024 | 65 | 0 | ||
| Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure : a case report and literature review | Frontiers in pediatrics | | 2024 | 26 | 78 | ||
| Reply to letter that comments on "Trigeminal nerve chronic motor denervation caused by cerebellar peduncle pilocytic astrocytoma" | Child's nervous system | | 2024 | 30 | 0 | ||
| Post-traumatic growth in parents of long-term childhood cancer survivors compared to the general population: A report from the Swiss childhood cancer survivor study-Parents | Psycho-oncology | | 2024 | 31 | 0 | ||
| Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry | Neuro-oncology advances | | 2024 | 12 | 10 | ||
| General support of physical exercise programs in pediatric oncology but differences in perception by childhood cancer care professionals at European and North-African/Arab centers | EJC paediatric oncology | | 2024 | 34 | 17 | ||
| Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare disease | Child's nervous system | | 2024 | 33 | 26 | ||
| Support Experiences and Wishes of Bereaved Parents After the Loss of Their Child to Cancer | Pediatric blood & cancer | | 2024 | 32 | 35 | ||
| Gliomatosis cerebri in children : A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile | Neuro-oncology | | 2024 | 26 | 16 | ||
| Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment | Neuro-oncology | | 2024 | 141 | 0 | ||
| Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups | Neuro-oncology | | 2023 | 21 | 13 | ||
| Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey-based cross-sectional study | Cancer reports | | 2023 | 142 | 67 | ||
| Worries and anxiety in parents of adult survivors of childhood cancer : A report from the Swiss Childhood Cancer Survivor Study‐Parents | Pediatric blood & cancer | | 2023 | 48 | 31 | ||
| Pediatric posterior fossa ATRT: a case report, new treatment strategies and perspectives | Brain sciences | | 2023 | 75 | 21 | ||
| Case report : Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023 ? | Frontiers in pharmacology | | 2023 | 68 | 23 | ||
| Palliative care services in paediatric oncology centres across Europe: A cross-sectional survey | EJC paediatric oncology | | 2023 | 27 | 26 | ||
| Médecine de précision dans le traitement des cancers pédiatriques | Revue médicale suisse | | 2023 | 24 | 34 | ||
| How I treat recurrent pediatric high-grade glioma (pHGG) : a Europe-wide survey study | Journal of neuro-oncology | | 2023 | 26 | 27 | ||
| Educational Attainment and Employment Outcome of Survivors of Pediatric CNS Tumors in Switzerland-A Report from the Swiss Childhood Cancer Survivor Study | Children | | 2022 | 58 | 19 | ||
| Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial | European journal of cancer | | 2022 | 42 | 0 | ||
| Neurological Symptom Improvement After Re-Irradiation in Patients With Diffuse Intrinsic Pontine Glioma : A Retrospective Analysis of the SIOP-E-HGG/DIPG Project | Frontiers in oncology | | 2022 | 57 | 19 | ||
| Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates | Neuro-oncology advances | | 2022 | 44 | 36 | ||
| Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol | BMJ open | | 2022 | 38 | 45 | ||
| Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma : experience from the German HIT-MED studies | Journal of neuro-oncology | | 2022 | 60 | 7 | ||
| Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data | Cancer reports | | 2021 | 229 | 147 | ||
| Transitioning to molecular diagnostics in pediatric high-grade glioma: experiences with the 2016 WHO classification of CNS tumors | Neuro-oncology advances | | 2021 | 135 | 60 | ||
| The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets | Cancer discovery | | 2021 | 152 | 122 | ||
| Trigeminal nerve chronic motor denervation caused by cerebellar peduncle pilocytic astrocytoma | Child's nervous system | | 2021 | 196 | 1 | ||
| Treatment of Embryonal Tumours with Multilayered Rosettes with Carboplatin/Etoposide Induction and High-dose Chemotherapy within the Prospective P-HIT Trial | Neuro-oncology | | 2021 | 129 | 0 | ||
| Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial | Advances in radiation oncology | | 2020 | 121 | 51 | ||
| Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort | Journal of clinical oncology | | 2020 | 173 | 0 | ||
| Cerebrospinal fluid evaluation in adult patients with medulloblastoma | Lancet. Oncology | | 2020 | 230 | 0 | ||
| CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort | Acta neuropathologica | | 2020 | 117 | 55 | ||
| Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome | Child's nervous system | | 2020 | 176 | 53 | ||
| Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment | PloS one | | 2020 | 168 | 86 | ||
| Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort | Acta neuropathologica communications | | 2019 | 102 | 103 | ||
| Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand? | Journal of neuro-oncology | | 2019 | 132 | 43 | ||
| Comment on: Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: a safety and feasibility study | Pediatric Blood and Cancer | | 2019 | 232 | 0 | ||
| Occurrence of high-grade glioma in Noonan syndrome: Report of two cases | Pediatric Blood and Cancer | | 2019 | 248 | 0 | ||
| Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience | European journal of cancer | | 2019 | 135 | 0 | ||
| Concurrent IDH1 and SMARCB1 Mutations in Pediatric Medulloblastoma: A Case Report | Frontiers in Neurology | | 2018 | 519 | 4 | ||
| Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location | Neuro-Oncology | | 2018 | 269 | 0 | ||
| A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)" | Acta Neuropathologica | | 2018 | 208 | 295 | ||
| Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients? | Journal of Neuro-Oncology | | 2018 | 259 | 103 | ||
| Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries | Journal of Clinical Oncology | | 2018 | 408 | 257 | ||
| Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients | Strahlentherapie und Onkologie | | 2018 | 252 | 0 | ||
| Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma | Cancer Cell | | 2017 | 370 | 253 | ||
| Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group | European Journal of Cancer | | 2017 | 402 | 0 | ||
| High-grade glioma in very young children: a rare and particular patient population | Oncotarget | | 2017 | 390 | 183 | ||
| Reverse phase protein arrays enable glioblastoma molecular subtyping | Journal of Neuro-Oncology | | 2017 | 420 | 0 | ||
| Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response | Child's Nervous System | | 2017 | 360 | 0 | ||
| Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification | PloS one | | 2017 | 119 | 61 | ||
| Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease | Journal of Neuro-Oncology | | 2017 | 361 | 141 | ||
| Haematological malignancies following temozolomide treatment for paediatric high-grade glioma | European Journal of Cancer | | 2017 | 423 | 0 | ||
| Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology | American Journal of Medical Genetics. A | | 2017 | 525 | 2 | ||
| A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015 | PloS one | | 2016 | 111 | 44 | ||
| Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters | Journal of clinical oncology | | 2016 | 133 | 0 | ||
| Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients? | Journal of Neuro-Oncology | | 2016 | 386 | 0 | ||
| Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome | Blood | | 2016 | 204 | 125 | ||
| Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy' | European journal of cancer | | 2016 | 114 | 0 | ||
| Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study | European Journal of Cancer | | 2016 | 478 | 1 | ||
| MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties | BMC Cancer | | 2016 | 476 | 254 | ||
| Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma | Child's Nervous System | | 2016 | 507 | 1 | ||
| Medulloblastoma in children and adults: one distinct disease entity? | Bulletin suisse du cancer | | 2016 | 459 | 48 | ||
| New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs | Cell | | 2016 | 263 | 89 | ||
| Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy | European journal of cancer | | 2015 | 166 | 0 | ||
| Early Childhood Medulloblastoma: Prognostic Factors | Pediatric Cancer | | 2012 | 210 | 0 | ||
| Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology | Neuro-oncology | | 2011 | 167 | 80 | ||
| RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells | BMC cancer | | 2009 | 418 | 63 |
